GlassScriptPhysician profile
Faisal A Arain
NPI 1144227752
$3,248.45
in general payments reported to CMS, 2019-2025
27 companies · $493 in 2025
The $493 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $566 · 2020: $252 · 2021: $249 · 2022: $450 · 2023: $576 · 2024: $662 · 2025: $493.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,731.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,731.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $599.54 | 2022-2025 | Watchman Flx, Watchman |
| Abbott Laboratories | $452.73 | 2019-2023 | Cardiomems |
| Teleflex LLC | $242.37 | 2023-2024 | Guideliner, Manta |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $232.85 | 2019-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $222.18 | 2021-2025 | Verquvo, Capvaxive |
| Abiomed | $166.19 | 2020 | |
| Biotronik INC. | $161.71 | 2019-2025 | Orsiro Mission |
| Amgen INC. | $131.67 | 2020-2025 | Repatha, Repatha |
| Philips North America LLC | $111.98 | 2024 | (Bh4) Igt Devices Undivided |
| Stryker Corporation | $111.29 | 2025 | Artix Mt, Inthrill Thrombectomy Catheter |
| E.R. Squibb & Sons, L.L.C. | $97.50 | 2019-2025 | Eliquis, Camzyos |
| Tactile Systems Technology INC | $96.35 | 2024-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Pfizer INC. | $91.65 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $84.16 | 2019-2025 | |
| Inspire Medical Systems, INC. | $74.17 | 2023 | Inspire |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $60.84 | 2019-2024 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $57.26 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $44.72 | 2019-2022 | |
| Lexicon Pharmaceuticals, INC. | $39.87 | 2023-2024 | Inpefa |
| Medtronic, INC. | $36.56 | 2022-2024 | Cobalt Dr Mri Surescan |
| Novo Nordisk INC | $33.22 | 2024 | Ozempic, Rybelsus |
| Amarin Pharma, INC. | $23.52 | 2023 | |
| Heartflow, INC. | $19.27 | 2023 | Ffrct |
| Scpharmaceuticals INC. | $18.01 | 2025 | |
| Avinger INC. | $14.38 | 2021 | |
| Kiniksa Pharmaceuticals, LTD. | $13.43 | 2022 | |
| Vifor Pharma, INC. | $11.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Faisal Arain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.